UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulation (New York, N.Y.), 2006-02, Vol.113 (5), p.671-678

2006

Volltextzugriff (PDF)

Predictors of mortality and morbidity in patients with chronic heart failure

European heart journal, 2006-01, Vol.27 (1), p.65-75

2006

Volltextzugriff (PDF)

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

European journal of heart failure, 2014-01, Vol.16 (1), p.33-40

2014

Volltextzugriff (PDF)

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-06, Vol.115 (24), p.3111-3120

2007

Volltextzugriff (PDF)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Volltextzugriff (PDF)

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2006-02, Vol.113 (7), p.986-994

2006

Volltextzugriff (PDF)

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

European heart journal, 2008-11, Vol.29 (21), p.2641-2650

2008

Volltextzugriff (PDF)

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Diabetes care, 2009-05, Vol.32 (5), p.915-920

2009

Volltextzugriff (PDF)

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2008-12, Vol.52 (24), p.2000-2007

2008

Volltextzugriff (PDF)

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

The American heart journal, 2006-05, Vol.151 (5), p.985-991

2006

Volltextzugriff (PDF)

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

JAMA : the journal of the American Medical Association, 2005-10, Vol.294 (14), p.1794

2005

Volltextzugriff (PDF)

Dual Renin-Angiotensin System Blockade in Heart Failure

Journal of the American College of Cardiology, 2009-07, Vol.54 (3), p.278-278

2009

Volltextzugriff (PDF)

Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme

European journal of heart failure, 2007-05, Vol.9 (5), p.510-517

2007

Volltextzugriff (PDF)

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Neonatology (Basel, Switzerland), 2017-01, Vol.112 (1), p.87-91

2017

Volltextzugriff (PDF)

Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2006-06, Vol.27 (12), p.1447-1458

2006

Volltextzugriff (PDF)

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

Circulation (New York, N.Y.), 2005-07, Vol.112 (1), p.48-53

2005

Volltextzugriff (PDF)

Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

The American journal of cardiology, 2008-09, Vol.102 (6), p.733-737

2008

Volltextzugriff (PDF)

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and Left ventricular systolic dysfunction : Results of the CHARM low-left ventricular ejection fraction trials

Circulation (New York, N.Y.), 2004-10, Vol.110 (17), p.2618-2626

2004

Volltextzugriff (PDF)

Adherence to medication according to sex and age in the CHARM programme

European journal of heart failure, 2009-11, Vol.11 (11), p.1092-1098

2009

Volltextzugriff (PDF)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

European heart journal, 2013-10, Vol.34 (39), p.3035-3087

2013

Volltextzugriff (PDF)

Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

European journal of heart failure, 2005-06, Vol.7 (4), p.650-656

2005

Volltextzugriff (PDF)

Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival

Journal of internal medicine, 2014, Vol.276 (1), p.87-95

2014

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaKardiologi

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Predictors of mortality and morbidity in patients with chronic heart failure

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

Dual Renin-Angiotensin System Blockade in Heart Failure

Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Resource utilization and costs in the Candesartan in Heart failure : Assessment of Reduction in Mortality and morbidity (CHARM) programme

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and Left ventricular systolic dysfunction : Results of the CHARM low-left ventricular ejection fraction trials

Adherence to medication according to sex and age in the CHARM programme

Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival

Aktive Filter

Suchergebnisse filtern